跳至主要内容
临床试验/NCT00986297
NCT00986297已完成1 期

Phase 1 Study of Accelerated Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-IV Non-Small Cell Lung Cancer and Poor Performance Status

University of Texas Southwestern Medical Center4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
60
试验地点
4
主要终点
Dose-limiting toxicity

研究概览

简要总结

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

PURPOSE: This phase I trial is studying the side effects and best dose of specialized radiation therapy in treating patients with stage II, stage III, stage IV, or recurrent non-small cell lung cancer and poor performance status.

详细描述

OBJECTIVES:

Primary

  • To escalate the dose of accelerated hypofractionated image-guided conformal radiotherapy to a potent tumoricidal dose without exceeding the maximum-tolerated dose in patients with recurrent or stage II-IV non-small cell lung cancer and poor performance status.

Secondary

  • To evaluate local regional tumor control and overall survival of patients treated with this regimen.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Dose-limiting toxicity

时间窗: 90 days

次要结局

  • Local regional tumor control(6 month)
  • Overall survival(2 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验